MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001) Meeting Abstract

  

Authors:	Gupta, S.; Ballman, K. V.; Galsky, M. D.; Morris, M. J.; Chen, R. C.; Chan, T. A.; Dercle, L.; Wen, Y.; Sridhar, S. S.; Yen, A. E.; Grivas, P.; Tan, A.; Baghaie, S.; Rosenberg, J. E.
Abstract Title:	MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001)
Meeting Title:	2022 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	40
Issue:	16 Suppl.
Meeting Dates:	2022 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2022-06-01
Language:	English
ACCESSION:	WOS:000863680304959
PROVIDER:	wos
DOI:	10.1200/JCO.2022.40.16_suppl.TPS4607
Notes:	Meeting Abstract: TPS4607 -- This meeting was also held virtually -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/201392